Interferome v2.0: an updated database of annotated interferon-regulated genes. Nucleic Acids Res 41: D1040–1046 (2013)
Citations: | 15 - 1 self |
Citations
3410 |
Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium
- Ashburner, Ball, et al.
(Show Context)
Citation Context ...the gene ontologies (GO) that occur more frequently are presented in larger font. Clicking on a GO term in this cloud links to the relevant record in the GO database [http:// amigo.geneontology.org/; =-=(30)-=-]. In addition the data are presented in a tabular format containing columns for GO accession number, term name, definition and P value to facilitate further downstream analysis. TF Analysis—presents ... |
851 | Exploration, normalization, and summaries of high density oligonucleotide array probe level data.
- Irizarry
- 2003
(Show Context)
Citation Context ...- or down-regulation. The pre-processing of the array data was platform- and array design-specific. Raw data from Affimetrix arrays were normalized using the Robust Multi-array Averaging (RMA) method =-=(23)-=-, which consisted of three steps: background adjustment, quantile normalization (24) and summarization (25). For some experiments, only processed data were available, and these data were only used if ... |
794 |
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias.
- Bolstad, Irizarry, et al.
- 2003
(Show Context)
Citation Context ...esign-specific. Raw data from Affimetrix arrays were normalized using the Robust Multi-array Averaging (RMA) method (23), which consisted of three steps: background adjustment, quantile normalization =-=(24)-=- and summarization (25). For some experiments, only processed data were available, and these data were only used if they had been processed and normalized using RMA, GeneChip RMA (GCRMA) or MicroArray... |
470 | Summaries of affymetrix genechip probe level data
- Irizarry, Boldstad, et al.
(Show Context)
Citation Context ...a from Affimetrix arrays were normalized using the Robust Multi-array Averaging (RMA) method (23), which consisted of three steps: background adjustment, quantile normalization (24) and summarization =-=(25)-=-. For some experiments, only processed data were available, and these data were only used if they had been processed and normalized using RMA, GeneChip RMA (GCRMA) or MicroArray Suite (MAS5) methods. ... |
435 | Statistical methods for identifying differentially expressed genes in replicated cDNA microarray experiments. Statistica Sinica 12
- Dudoit, Yang, et al.
- 2002
(Show Context)
Citation Context ...ated samples with appropriate controls. All data were log2 transformed before analysis. The statistical significance of any differences in gene expression was tested using a paired or unpaired t-test =-=(28,29)-=-. The Welch t-test was adopted to avoid any assumption of equal variance; previous analysis had indicated that the Welch t-test tended to be more conservative and so less likely to return false than o... |
378 | Functional role of type I and type II interferons in antiviral defense. - Muller - 1918 |
273 |
Pattern recognition receptors and inflammation,”
- Takeuchi, Akira
- 2010
(Show Context)
Citation Context ...d in different physiological and pathological circumstances, thus identifying a role for IFNs in such diverse diseases as autoimmunity, cancer, diabetes, neurodegeneration and developmental anomalies =-=(19)-=-. It remains unclear how IFN contributes to the pathogenesis of these diseases. The existence of genomic technologies such as microarrays has enabled the genome-wide assessment of changes in gene expr... |
242 | Normalization of cdna microarray data
- Smyth, Speed
- 2003
(Show Context)
Citation Context ...on to the 75th percentile was performed to remove technical variations between individual arrays. Data from two-colour arrays were normalized applying normalizeWithinArrays and normalizeBetweenArrays =-=(26,27)-=-. Data from any replicated probes were averaged to provide a single measure for each probe in the array. All Agilent control probes were removed. Normalized probes from both microarray platforms were ... |
239 | Use of within-array replicate spots for assessing differential expression in microarray experiments.
- GK, Michaud, et al.
- 2005
(Show Context)
Citation Context ...on to the 75th percentile was performed to remove technical variations between individual arrays. Data from two-colour arrays were normalized applying normalizeWithinArrays and normalizeBetweenArrays =-=(26,27)-=-. Data from any replicated probes were averaged to provide a single measure for each probe in the array. All Agilent control probes were removed. Normalized probes from both microarray platforms were ... |
219 |
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays
- Der, Zhou, et al.
- 1998
(Show Context)
Citation Context ...nase, MAP kinase and others (13). The activation of these many signal transduction pathways leads to activated transcription factors binding to promoters and regulating the expression of sets of IRGs =-=(14)-=-. It is the nature of the genes, their magnitude, duration and cellular context that will determine the outcome of the IFN response. This response will vary from cell to cell and can be beneficial or ... |
202 |
A comparative review of statistical methods for discovering differentially expressed genes in replicated microarray experiments
- Pan
- 2002
(Show Context)
Citation Context ...ated samples with appropriate controls. All data were log2 transformed before analysis. The statistical significance of any differences in gene expression was tested using a paired or unpaired t-test =-=(28,29)-=-. The Welch t-test was adopted to avoid any assumption of equal variance; previous analysis had indicated that the Welch t-test tended to be more conservative and so less likely to return false than o... |
107 |
Mechanisms of type-I- and type-II-interferon-mediated signaling
- Platanias
- 2005
(Show Context)
Citation Context ...ctivate STATs 1, 2, 3, 4, 5 and 6 depending on the type of IFN and the target cell (12). In addition, there are non-STAT signalling pathways also activated including PI3 kinase, MAP kinase and others =-=(13)-=-. The activation of these many signal transduction pathways leads to activated transcription factors binding to promoters and regulating the expression of sets of IRGs (14). It is the nature of the ge... |
105 |
Interferons, interferon-like cytokines, and their receptors,”
- Pestka, Krause, et al.
- 2004
(Show Context)
Citation Context ...subtypes), type II (a single IFNg) and type III (IFN; also called IL28 and IL29), which are distinguished by having distinct genetic loci, amino acid sequence homology and specific cognate receptors =-=(3)-=-. All IFNs can have numerous effects on cells, including the ability to modulate growth, differentiation, proliferation, survival/ apoptosis and motility. In the immune system, these basic properties ... |
55 |
Type I interferon: friend or foe?
- Trinchieri
- 2010
(Show Context)
Citation Context ...e, there are clinical trials of reagents to block IFN activity in diseases such as Systemic Lupus Erythematosus (9). Administration of IFN also has side effects associated with dose-limiting toxicity =-=(10)-=-. As a consequence, there is considerable interest in understanding the regulation of IFN signalling: how each signal transduction pathway is activated or suppressed; what biological effects are attri... |
36 | A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses - Hwang, Hertzog, et al. - 1995 |
22 | An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis,”
- Berry, Graham, et al.
- 2010
(Show Context)
Citation Context ...n the Interferome, has highlighted the association of pathways activated by IFNs in a broad range of diseases, including influenza outbreaks (32), hepatitis (33), HIV (34), Mycobacterium tuberculosis =-=(35)-=-, breast cancer metastases (36) and autoimmune disorders (37). Annotation of these pathways holds considerable promise for the development of refined diagnostics and new therapies and vaccines. Databa... |
18 |
3rd et al. (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources
- Wu, Orozco, et al.
(Show Context)
Citation Context ... expression of IRGs in their resting, unstimulated state, across various tissues and cells. The human and mouse expression data were obtained from the tissues and cell lines data in the BioGPS portal =-=(31)-=-. The IRG list resulting from the search is plotted against expression in these tissues and cells, with red indicating high expression and blue low expression. All ‘Secondary Search’ results can be do... |
17 |
Type I interferon receptors: biochemistry and biological functions
- Weerd, Samarajiwa, et al.
- 2007
(Show Context)
Citation Context ... biological effects are attributed to which pathways; and how they can be differentially modulated. Once an IFN has engaged its cognate receptor, a series of events are activated to transduce signals =-=(11)-=-. The IFN receptors are pre-associated with pairs of JAK kinases which, once activated by the ligand binding to its receptor, phosphorylate tyrosine residues on each other and on the intracellular dom... |
11 |
The jak-stat pathway at twenty
- Stark, Darnell
(Show Context)
Citation Context ...er elements], the range of signals that are generated from ligated receptors is far more complex. In fact, IFNs can activate STATs 1, 2, 3, 4, 5 and 6 depending on the type of IFN and the target cell =-=(12)-=-. In addition, there are non-STAT signalling pathways also activated including PI3 kinase, MAP kinase and others (13). The activation of these many signal transduction pathways leads to activated tran... |
11 | Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system - Vance, Isberg, et al. - 2009 |
10 |
Direct effects of type I interferons on cells of the immune system,”
- Hervas-Stubbs, Perez-Gracia, et al.
- 2011
(Show Context)
Citation Context ...ntiation, proliferation, survival/ apoptosis and motility. In the immune system, these basic properties result in the ability of IFNs to regulate the development and activities of most effector cells =-=(4,5)-=-. They can affect most cells in the body that express the cognate receptors, albeit differently. Consequently, they have wide ranging effects on homeostasis and pathology. IFNs are involved in the hos... |
10 | INTERFEROME: the database of interferon regulated genes
- Samarajiwa, Forster, et al.
- 2009
(Show Context)
Citation Context ...ivated, we embarked on a project to collect and annotate a comprehensive list of IFN-regulated genes, associated data and pathway predictions and established the Interferome DB (www. interferome.org) =-=(20)-=-. Since its publication in 2009, it has received >2 million hits, has 48 citations in eminent journals and we have had considerable feedback requesting additional functionality or access; refer databa... |
8 |
BASE—2nd generation software for microarray data management and analysis
- Vallon-Christersson
- 2009
(Show Context)
Citation Context ... analysis. Data pre-processing For the storage, management and statistical analysis of microarray experiments from different platforms, the BioArray Software Environment (BASE) server was established =-=(22)-=-. This processing represents a significant improvement in Interferome v2.0 compared with the original Interferome (‘v1.0’) which included only qualitative up- or down-regulation. The pre-processing of... |
7 |
The role of type I interferons in TLR responses
- Noppert, Fitzgerald, et al.
- 2007
(Show Context)
Citation Context ...ar context that will determine the outcome of the IFN response. This response will vary from cell to cell and can be beneficial or harmful to the host. IFNs are produced in a variety of circumstances =-=(15)-=-. In recent years, there has been a revolution in understanding the innate immune system, which evolved to recognize bacteria, viruses and other pathogens, and then to mount an immediate response and ... |
5 |
Pouvoir immunisant du virus vaccinal inactive par des rayons ultraviolets
- Nagano, Kojima
(Show Context)
Citation Context ...fication of gene signatures of importance in the pathogenesis of these diseases. INTRODUCTION Interferon (IFN) was discovered and defined as a protein with the ability to protect cells from infection =-=(1,2)-=-. It has been subsequently realized that there is a large family of IFN proteins that have pleiotrophic effects. There are three types of IFNs, namely type I (composed of a, b, k, e and o subtypes), t... |
5 | Cancer immunotherapy: the interferon-alpha experience. - KIRKWOOD - 2002 |
5 |
Emerging therapies for systemic lupus erythematosus—focus on targeting interferon-alpha,”
- Lichtman, Helfgott, et al.
- 2012
(Show Context)
Citation Context ...Ns varies over 1000-fold. Because IFNs may also contribute to the pathogenesis of disease, there are clinical trials of reagents to block IFN activity in diseases such as Systemic Lupus Erythematosus =-=(9)-=-. Administration of IFN also has side effects associated with dose-limiting toxicity (10). As a consequence, there is considerable interest in understanding the regulation of IFN signalling: how each ... |
5 |
HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN production
- Harman, Lai, et al.
- 2011
(Show Context)
Citation Context ...s, such as those made available in the Interferome, has highlighted the association of pathways activated by IFNs in a broad range of diseases, including influenza outbreaks (32), hepatitis (33), HIV =-=(34)-=-, Mycobacterium tuberculosis (35), breast cancer metastases (36) and autoimmune disorders (37). Annotation of these pathways holds considerable promise for the development of refined diagnostics and n... |
4 |
Systems biology of interferon responses
- Hertzog, Forster, et al.
- 2011
(Show Context)
Citation Context ...ation in 2009, it has received >2 million hits, has 48 citations in eminent journals and we have had considerable feedback requesting additional functionality or access; refer database statistics and =-=(21)-=-. We herein describe an update of the Interferome DB called v2.0 (http://interferome.its. monash.edu.au/interferome/). In summary, there has been a significant improvement in computational infrastruct... |
2 |
Analysis of the cumulative changes in Graves’ disease thyroid glands points to IFN signature, plasmacytoid DCs and alternatively activated macrophages as chronicity determining factors
- Ruiz-Riol, Mdel, et al.
- 2011
(Show Context)
Citation Context ...s activated by IFNs in a broad range of diseases, including influenza outbreaks (32), hepatitis (33), HIV (34), Mycobacterium tuberculosis (35), breast cancer metastases (36) and autoimmune disorders =-=(37)-=-. Annotation of these pathways holds considerable promise for the development of refined diagnostics and new therapies and vaccines. Databases such as the Interferome with related sites together with ... |
1 |
Virus interference: part I. The interferon
- Isaacs, Lindenmann
- 1957
(Show Context)
Citation Context ...fication of gene signatures of importance in the pathogenesis of these diseases. INTRODUCTION Interferon (IFN) was discovered and defined as a protein with the ability to protect cells from infection =-=(1,2)-=-. It has been subsequently realized that there is a large family of IFN proteins that have pleiotrophic effects. There are three types of IFNs, namely type I (composed of a, b, k, e and o subtypes), t... |
1 |
Overview. Type I interferons as primers, activators and inhibitors of innate and adaptive immune responses
- Hertzog
- 2012
(Show Context)
Citation Context ...ntiation, proliferation, survival/ apoptosis and motility. In the immune system, these basic properties result in the ability of IFNs to regulate the development and activities of most effector cells =-=(4,5)-=-. They can affect most cells in the body that express the cognate receptors, albeit differently. Consequently, they have wide ranging effects on homeostasis and pathology. IFNs are involved in the hos... |
1 | Interferon-alpha for patients with chronic hepatitis delta: a systematic review of randomized clinical trials - Lamers, Kirgiz, et al. - 2012 |
1 | Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis - Croze, Yamaguchi, et al. - 2012 |
1 |
Pregnant women have attenuated innate interferon responses to 2009 pandemic influenza A virus subtype H1N1
- Forbes, Wark, et al.
- 2012
(Show Context)
Citation Context ...ments in analytical methods, such as those made available in the Interferome, has highlighted the association of pathways activated by IFNs in a broad range of diseases, including influenza outbreaks =-=(32)-=-, hepatitis (33), HIV (34), Mycobacterium tuberculosis (35), breast cancer metastases (36) and autoimmune disorders (37). Annotation of these pathways holds considerable promise for the development of... |
1 |
Database issue D1045 et al. (2009) IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin
- Suppiah, Moldovan, et al.
(Show Context)
Citation Context ...cal methods, such as those made available in the Interferome, has highlighted the association of pathways activated by IFNs in a broad range of diseases, including influenza outbreaks (32), hepatitis =-=(33)-=-, HIV (34), Mycobacterium tuberculosis (35), breast cancer metastases (36) and autoimmune disorders (37). Annotation of these pathways holds considerable promise for the development of refined diagnos... |
1 |
et al. (2012) Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
- Bidwell, Slaney, et al.
(Show Context)
Citation Context ...ted the association of pathways activated by IFNs in a broad range of diseases, including influenza outbreaks (32), hepatitis (33), HIV (34), Mycobacterium tuberculosis (35), breast cancer metastases =-=(36)-=- and autoimmune disorders (37). Annotation of these pathways holds considerable promise for the development of refined diagnostics and new therapies and vaccines. Databases such as the Interferome wit... |